Eam Investors, LLC Rx Sight, Inc. Transaction History

Eam Investors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$50.42 - $64.29 $22,386 - $28,544	-444 Reduced 0.46%	95,607 $5.75 Million
Q1 2024 May 13, 2024	SELL	$35.51 - $57.92 $399,807 - $652,121	-11,259 Reduced 10.49%	96,051 $4.95 Million
Q4 2023 Feb 13, 2024	SELL	$20.91 - $40.9 $1.17 Million - $2.28 Million	-55,858 Reduced 34.23%	107,310 $4.33 Million
Q3 2023 Nov 13, 2023	SELL	$27.05 - $33.37 $1.58 Million - $1.94 Million	-58,247 Reduced 26.31%	163,168 $4.55 Million
Q2 2023 Aug 11, 2023	BUY	$16.37 - $28.9 $810,904 - $1.43 Million	49,536 Added 28.82%	221,415 $6.38 Million
Q1 2023 Jul 12, 2023	BUY	$12.58 - $16.68 $2.16 Million - $2.87 Million	171,879 New	171,879 $2.87 Million
Q2 2022 Aug 12, 2022	BUY	$10.61 - $16.66 $1.87 Million - $2.94 Million	176,270 New	176,270 $2.48 Million

225

32.3M

394K

32K

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.27B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.